Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tincani

Showing results (21-30 of 230) with videos related to

Pageof 23
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1993
ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE)R A Sinico, C Pozzi, A Radice, et al.
Lupus|May 21, 2008
Pathogenic anti-nucleosome antibodiesS Muller, J Dieker, A Tincani, et al.
Autoimmunity Reviews|October 31, 2007
Inflammatory molecules: a target for treatment of systemic autoimmune diseasesA Tincani, L Andreoli, C Bazzani, et al.
Acta Haematologica|January 1, 1983
Detection of circulating immune complexes in acute non-lymphatic leukaemia: is it reliable?G Rossi, G Balestrieri, A Tincani, et al.
Case Reports in Rheumatology|April 4, 2018
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab TreatmentM Filippini, S Cartella, O Bonzanini, et al.
Lupus|August 23, 2007
Contraception in adolescents with systemic lupus erythematosusA Tincani, M Nuzzo, A Lojacono, et al.
Lupus|October 26, 2017
Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princessD Pérez, A Tincani, M Serrano, et al.
Lupus|April 1, 2010
Antiphospholipid antibody profile: implications for the evaluation and management of patientsA Tincani, L Andreoli, C Casu, et al.
Reumatismo|April 15, 2010
[Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations]A Tincani, C Casu, S Cartella, et al.
Annals of the Rheumatic Diseases|May 22, 2003
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosisC M Antonioli, E Danieli, P Airò, et al.
Pageof 23

Showing results (21-30 of 230) with videos related to

Sort By:
Pageof 23
Advances in Experimental Medicine and Biology|January 1, 1993
ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE)R A Sinico, C Pozzi, A Radice, et al.
Lupus|May 21, 2008
Pathogenic anti-nucleosome antibodiesS Muller, J Dieker, A Tincani, et al.
Autoimmunity Reviews|October 31, 2007
Inflammatory molecules: a target for treatment of systemic autoimmune diseasesA Tincani, L Andreoli, C Bazzani, et al.
Acta Haematologica|January 1, 1983
Detection of circulating immune complexes in acute non-lymphatic leukaemia: is it reliable?G Rossi, G Balestrieri, A Tincani, et al.
Case Reports in Rheumatology|April 4, 2018
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab TreatmentM Filippini, S Cartella, O Bonzanini, et al.
Lupus|August 23, 2007
Contraception in adolescents with systemic lupus erythematosusA Tincani, M Nuzzo, A Lojacono, et al.
Lupus|October 26, 2017
Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princessD Pérez, A Tincani, M Serrano, et al.
Lupus|April 1, 2010
Antiphospholipid antibody profile: implications for the evaluation and management of patientsA Tincani, L Andreoli, C Casu, et al.
Reumatismo|April 15, 2010
[Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations]A Tincani, C Casu, S Cartella, et al.
Annals of the Rheumatic Diseases|May 22, 2003
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosisC M Antonioli, E Danieli, P Airò, et al.
Pageof 23